Procter & Gamble Announces Major Workforce Restructuring Amid Stock Challenges

Consumer goods titan Procter & Gamble has unveiled a significant corporate overhaul, revealing plans to eliminate 7,000 positions globally by mid-2027. This dramatic workforce reduction represents one of the company’s most substantial restructuring efforts in recent years, generating mixed reactions from market observers. While some view the move as a necessary efficiency improvement, others express concerns about potential impacts on the heritage company’s innovation capabilities. The central question remains whether this strategic shift can revitalize the company’s underperforming stock.

Market Performance and Technical Indicators Signal Concerns

The company’s equity performance reveals persistent challenges. Technical analysis shows the 50-day moving average trading substantially below the 200-day average—a pattern market technicians typically interpret as a bearish signal. This negative momentum has persisted through a six-day losing streak earlier in the month, with shares continuing to face downward pressure.

The current trading level highlights the extent of the decline, standing significantly below the 52-week peak of over $180 per share. This represents a notable correction for what has historically been considered a stable dividend-paying investment.

Institutional Investors Display Divergent Strategies

Recent regulatory filings reveal a divided sentiment among professional investment firms. Smith Salley Wealth Management increased its stake by 2.4%, while Addenda Capital substantially boosted its position with a 28.2% purchase increase. In contrast, ERn Financial dramatically reduced its exposure by slashing its holding by 72%.

Should investors sell immediately? Or is it worth buying Procter & Gamble?

Adding to the cautious sentiment, corporate insiders have been selling shares from their personal portfolios. This divergence in institutional and insider activity reflects the uncertainty surrounding P&G’s new strategic direction.

Financial Metrics and Analyst Outlook

Despite the turbulent environment, research analysts maintain a cautiously optimistic “Moderate Buy” consensus rating. The average price target sits at $173.68, representing substantial potential upside from current levels. The company’s most recent quarterly performance exceeded expectations, with earnings of $1.48 per share alongside a 1.7% revenue increase.

The dividend distribution remains stable at slightly over $1.00 per quarter. However, market participants continue to evaluate whether these positive elements will be sufficient to restore full investor confidence amid the ongoing restructuring initiative.

The workforce reduction, announced in September 2025, will primarily affect non-manufacturing functions. Company leadership indicates the restructuring aims to reallocate resources toward innovation initiatives and core brand development, representing a strategic response to slowing sales and increasing investor pressure for enhanced cost efficiency.